Literature DB >> 8298804

Effects of the novel potassium channel opener, UR-8225, on contractile responses in rat isolated smooth muscle.

F Perez-Vizcaino1, O Casis, R Rodriguez, L A Gomez, J Garcia Rafanell, J Tamargo.   

Abstract

1. The effects of UR-8225 [(1,2-dihydro-4-(1,2-dihydro-2-oxo-1-pyridyl)-2,2-dimethyl-1-oxonapht halen-6- carbonitrile)] and levcromakalim were studied on the electrical and contractile responses induced by noradrenaline and KCl and on 86Rb+ efflux in rat aortic rings and on spontaneous mechanical activity in rat portal vein segments. 2. UR-8225 and levcromakalim, 10(-9) M-10(-5) M, relaxed the contractile responses induced by noradrenaline (IC50 = 2.7 +/- 0.4 x 10(-6) M and 6.6 +/- 1.3 x 10(-7) M, respectively) or 30 mM KCl (IC50 = 1.4 +/- 0.2 x 10(-7) M and 9.4 +/- 1.3 x 10(-8) M, respectively) more effectively than those induced by 80 mM KCl. The relaxant effect on noradrenaline-induced contractions was independent of the presence or absence of functional endothelium. 3. The vasorelaxant effect of UR-8225 and levcromakalim can be competitively antagonized by glibenclamide, an ATP-sensitive K+ channel blocker. There were no differences in the calculated pA2 values for glibenclamide to inhibit UR-8225- and levcromakalim-induced relaxations (7.61 +/- 0.08 and 7.69 +/- 0.10, respectively). The slope of the Schild plot yielded values not significantly different from unity (0.95 +/- 0.06 and 0.96 +/- 0.05, respectively). 4. UR-8225 (10(-5) M) hyperpolarized the resting aortic membrane potential from -50.7 +/- 0.7 mV to -66.0 +/- 2.0 mV and stimulated 86Rb+ efflux. 5. UR-8225 and levcromakalim inhibited the contractions induced by Ca2+ in aortae incubated in Ca(2+)-free PSS containing methoxyverapamil in the presence of noradrenaline. 6. Both drugs inhibited the amplitude of spontaneous activity in portal veins (IC50 = 5.1 +/- 1.4 x 10-8 M and 1.5 +/- 0.7 x 10-8 M, respectively), this effect being competitively antagonized by glibenclamide.7. These results indicated that UR-8225 exhibited qualitatively similar, but slightly less potent,vasorelaxant effects than those exerted by levcromakalim, which suggests that they can be related to its ability to activate ATP-sensitive K+ channels in vascular smooth muscle cells.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8298804      PMCID: PMC2175824          DOI: 10.1111/j.1476-5381.1993.tb13936.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  23 in total

Review 1.  Structure-activity relationships of K+ channel openers.

Authors:  G Edwards; A H Weston
Journal:  Trends Pharmacol Sci       Date:  1990-10       Impact factor: 14.819

Review 2.  Cromakalim, nicorandil and pinacidil: novel drugs which open potassium channels in smooth muscle.

Authors:  T C Hamilton; A H Weston
Journal:  Gen Pharmacol       Date:  1989

3.  Effect of apamin on responses to BRL 34915, nicorandil and other relaxants in the guinea-pig taenia caeci.

Authors:  S W Weir; A H Weston
Journal:  Br J Pharmacol       Date:  1986-05       Impact factor: 8.739

Review 4.  The pharmacology of potassium channels and their therapeutic potential.

Authors:  N S Cook
Journal:  Trends Pharmacol Sci       Date:  1988-01       Impact factor: 14.819

Review 5.  Sympathetic neuroeffector transmission in arteries and arterioles.

Authors:  G D Hirst; F R Edwards
Journal:  Physiol Rev       Date:  1989-04       Impact factor: 37.312

6.  Voltage dependence of inositol 1,4,5-trisphosphate-induced Ca2+ release in peeled skeletal muscle fibers.

Authors:  S K Donaldson; N D Goldberg; T F Walseth; D A Huetteman
Journal:  Proc Natl Acad Sci U S A       Date:  1988-08       Impact factor: 11.205

7.  Effects of BRL 34915, a putative K channel opener, on transmembrane 45Ca movements in rabbit aortic smooth muscle.

Authors:  P J Chiu; G Tetzloff; H S Ahn; E J Sybertz
Journal:  Eur J Pharmacol       Date:  1988-10-18       Impact factor: 4.432

8.  Evidence that the mechanism of the inhibitory action of pinacidil in rat and guinea-pig smooth muscle differs from that of glyceryl trinitrate.

Authors:  K M Bray; D T Newgreen; R C Small; J S Southerton; S G Taylor; S W Weir; A H Weston
Journal:  Br J Pharmacol       Date:  1987-06       Impact factor: 8.739

9.  Noradrenaline contracts arteries by activating voltage-dependent calcium channels.

Authors:  M T Nelson; N B Standen; J E Brayden; J F Worley
Journal:  Nature       Date:  1988-11-24       Impact factor: 49.962

10.  Effects of (S)-nafenodone on 45Ca2+ fluxes and contractions in rat isolated vascular smooth muscle.

Authors:  F Pérez-Vizcaíno; R Carrón; E Delpón; J Duarte; J Tamargo
Journal:  Eur J Pharmacol       Date:  1993-02-23       Impact factor: 4.432

View more
  5 in total

1.  Effects of nicorandil as compared to mixtures of sodium nitroprusside and levcromakalim in isolated rat aorta.

Authors:  A L Cogolludo; F Pérez-Vizcaíno; S Fajardo; M Ibarra; J Tamargo
Journal:  Br J Pharmacol       Date:  1999-02       Impact factor: 8.739

2.  Vasodilator effects of sodium nitroprusside, levcromakalim and their combination in isolated rat aorta.

Authors:  F Pérez-Vizcaíno; A L Cogolludo; F Zaragozá-Arnáez; S Fajardo; M Ibarra; J G López-López; J Tamargo
Journal:  Br J Pharmacol       Date:  1999-12       Impact factor: 8.739

3.  Group B Streptococcus and E. coli LPS-induced NO-dependent hyporesponsiveness to noradrenaline in isolated intrapulmonary arteries of neonatal piglets.

Authors:  E Villamor; F Pérez-Vizcaíno; T Ruiz; J C Leza; M Moro; J Tamargo
Journal:  Br J Pharmacol       Date:  1995-05       Impact factor: 8.739

4.  Study of the in vivo and in vitro cardiovascular effects of (+)-glaucine and N-carbethoxysecoglaucine in rats.

Authors:  F Orallo; A Fernández Alzueta; M Campos-Toimil; J M Calleja
Journal:  Br J Pharmacol       Date:  1995-04       Impact factor: 8.739

5.  Contribution of trace element exposure to gestational diabetes mellitus through disturbing the gut microbiome.

Authors:  Yuqing Zhang; Ting Chen; Yiyun Zhang; Qi Hu; Xu Wang; Hang Chang; Jian-Hua Mao; Antoine M Snijders; Yankai Xia
Journal:  Environ Int       Date:  2021-03-25       Impact factor: 13.352

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.